BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8207)

  • 1. Understanding neurotransmitters and related drugs.
    Doughty B; Crozier J
    Can Nurse; 1976 Aug; 72(8):38-42. PubMed ID: 8207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of action of antiepileptic drugs. Experimental results on the role of neurotransmitters (author's transl)].
    Löscher W
    Nervenarzt; 1981 Feb; 52(2):61-7. PubMed ID: 6111757
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychotropic drugs: mechanism of action at the neurotransmitter level.
    Preziosi P; Nisticò G
    Int J Clin Pharmacol Biopharm; 1977 Nov; 15(11):497-518. PubMed ID: 22501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
    Andén NE
    Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotransmitters and sleep.
    Mendelson WB
    J Clin Psychiatry; 2001; 62 Suppl 10():5-8. PubMed ID: 11388591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular aspects of transmitter release: calcium monoamine dynamics.
    Radouco-Thomas S
    Adv Cytopharmacol; 1971 May; 1():457-75. PubMed ID: 4148192
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-HT receptor regulation of neurotransmitter release.
    Fink KB; Göthert M
    Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Receptor diseases. 1: Disorders of adrenergic receptors, cholinergic receptors and neurotransmitters].
    Nestele M
    Med Monatsschr Pharm; 1989 May; 12(5):147-52. PubMed ID: 2567488
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlations between chemical mediators (dopamine, serotonin, acetylcholine and gaba), muscular tone and rapidity of movement].
    Hassler R
    Rev Neurol (Paris); 1972 Jul; 127(1):51-63. PubMed ID: 4358575
    [No Abstract]   [Full Text] [Related]  

  • 10. Neural pathways and neurotransmitters affecting melatonin synthesis.
    Ebadi M; Govitrapong P
    J Neural Transm Suppl; 1986; 21():125-55. PubMed ID: 2875124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of precursors on brain neurotransmitter synthesis and brain functions.
    Fernstrom JD
    Diabetologia; 1981 Mar; 20 Suppl():281-9. PubMed ID: 6112187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-adrenergic, non-cholinergic autonomic neurotransmission mechanisms.
    Burnstock G; Hökfelt T; Gershon MD; Iversen LL; Kosterlitz HW; Szurszewski JH
    Neurosci Res Program Bull; 1979 Jun; 17(3):377-519. PubMed ID: 42027
    [No Abstract]   [Full Text] [Related]  

  • 13. Some derivatives of 3-amino-2-oxazolidinone influencing neurotransmission of dopamine and serotonin.
    Chilmonczyk Z; Krzywda J; Cybulski J; Iskra-Jopa J
    Pharmazie; 1997 Feb; 52(2):152-7. PubMed ID: 9122275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of neuroeffector transmission.
    Rand MJ; Majewski H; Wong-Dusting H; Story DF; Loiacono RE; Ziogas J
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S33-44. PubMed ID: 2455191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of drugs on adrenergic nerve terminals.
    von Euler US
    Adv Cytopharmacol; 1971 May; 1():363-7. PubMed ID: 4148190
    [No Abstract]   [Full Text] [Related]  

  • 16. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain.
    Burchett SA; Hicks TP
    Prog Neurobiol; 2006 Aug; 79(5-6):223-46. PubMed ID: 16962229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic concepts of psychopharmacological research as applied to the psychopharmacological analysis of the amygdala.
    Richardson JS
    Acta Neurobiol Exp (Wars); 1974; 34(4):543-62. PubMed ID: 4154703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central neurotransmitter disturbances underlying developmental neurotoxicological effects.
    Mirmiran M; Swaab DF
    Neurotoxicology; 1986; 7(2):95-102. PubMed ID: 2878401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter interactions related to central dopamine neurons.
    Lloyd KG
    Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
    [No Abstract]   [Full Text] [Related]  

  • 20. The neurobiology of slow synaptic transmission.
    Greengard P
    Science; 2001 Nov; 294(5544):1024-30. PubMed ID: 11691979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.